本页面由Tiger Trade Technology Pte. Ltd.提供服务

Corcept医疗

82.28
+1.161.43%
盘后85.002.72+3.31%19:53 EST
成交量:109.28万
成交额:8,929.38万
市值:86.55亿
市盈率:94.20
高:82.98
开:81.19
低:79.02
收:81.12
52周最高:117.33
52周最低:49.00
股本:1.05亿
流通股本:8,687.53万
量比:0.88
换手率:1.26%
股息:- -
股息率:- -
每股收益(TTM):0.8735
每股收益(LYR):1.35
净资产收益率:16.70%
总资产收益率:5.10%
市净率:13.70
市盈率(LYR):60.79

数据加载中...

2024/05/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/17

重要事件披露

Form 8-K - Current report
2024/04/05

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/04/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/27

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/03/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/15

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/02/15

重要事件披露

Form 8-K - Current report
2024/02/15

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/12

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/02

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/08

重要事件披露

Form 8-K - Current report
2024/01/03

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/01/02

重要事件披露

Form 8-K - Current report
2023/12/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2023/12/12

重要事件披露

Form 8-K - Current report
2023/12/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities